Role of the endocannabinoid system in Alzheimer's disease: New perspectives

Life Sciences

Volumn 75, Issue 16, 2004, Pages 1907-1915

  Pazos, M R ^a   Nunez E ^a   Benito, C ^a   Tolon R M ^a   Romero, J ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

Alzheimer's disease; Endocannabinoids; Glia; Inflammation; Receptors

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST;

ALZHEIMER DISEASE; DENSITY; GLIA; GLIA CELL; HUMAN; INFLAMMATION; MEDICAL RESEARCH; NONHUMAN; PATHOGENESIS; REVIEW; SAMPLING;

EID: 4143121265     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.03.026     Document Type: Short Survey

References (41)

1. A. Arévalo-Marté-n, J.M. Vela, E. Molina-Holgado, J. Borrell, and C. Guaza Therapeutic actions of cannabinoids in a murine model of multiple sclerosis Journal of Neuroscience 23 2003 2511 2516
2. 2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains Journal of Neuroscience 23 2003 11136 11141
3. E.N. Benveniste, V.T. Nguyen, and G.M. O'Keefe Immunological aspects of microglia: relevance to Alzheimer's disease Neurochemistry International 39 2001 381 391
4. E. De Lago, J.J. Fernández-Ruiz, S. Ortega-Gutiérrez, A. Viso, M.L. López-Rodrí-guez, and J.A. Ramos UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide European Journal of Pharmacology 449 2002 99 103
5. D.G. Deutsch, N. Ueda, and S. Yamamoto The fatty acid amide hydrolase (FAAH) Prostaglandins Leukotrienes and Essential Fatty Acids 66 2002 201 210
6. T.P. Dinh, D. Carpenter, F.M. Leslie, T.F. Freund, I. Katona, S.L. Sensi, S. Kathuria, and D. Piomelli Brain monoglyceride lipase participating in endocannabinoid inactivation Proceedings of the National Academy of Sciences of the United States of America 99 2002 10819 10824
7. T.P. Dinh, T.F. Freund, and D. Piomelli A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation Chemistry and Physics of Lipids 121 2002 149 158
8. A. Giuffrida, M. Beltramo, and D. Piomelli Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology Journal of Pharmacology and Experimental Therapeutics 298 2001 7 14
9. D. Giulian Microglia and the immune pathology of Alzheimer's disease American Journal of Human Genetics 65 1999 13 18
10. S.T. Glaser, N.A. Abumrad, F. Fatade, M. Kaczocha, K.M. Studholme, and D.G. Deutsch Evidence against the presence of an anandamide transporter Proceedings of the National Academy of Sciences of the United States of America 100 2003 4269 4274
11. R.I. Grundy, M. Rabuffetti, and M. Beltramo Cannabinoids and neuroprotection Molecular Neurobiology 24 2001 29 51
12. M. Herkenham Localization of cannabinoid receptors in brain and periphery R.G. Pertwee Cannabinoid Receptors 1995 Academic Press New York, NY 145 166
13. T. Iuovone, G. Esposito, R. Esposito, R. Santamaria, M. Di Rosa, and A.A. Izzo Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells Journal of Neurochemistry 89 2004 134 141
14. A. Klegeris, C.J. Bissonnette, and P.L. McGeer Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor British Journal of Pharmacology 139 2003 775 786
15. T.W. Klein, C.A. Newton, and H. Friedman Cannabinoids and the immune system Pain Research Management 6 2001 95 101
16. A. Law, S. Gauthier, and R. Quirion Say NO to Alzheimer's Disease: the putative links between nitric oxide and dementia of the Alzheimer's type Brain Research Reviews 35 2001 73 96
17. A.H. Lichtman, E.G. Hawkins, G. Griffin, and B.F. Cravatt Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo Journal of Pharmacology and Experimental Therapeutics 302 2002 73 79
18. A.B. Lynn, and M. Herkenham Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids Journal of Pharmacology and Experimental Therapeutics 268 1994 1612 1623
19. R.B. Maccioni, J.P. Muñoz, and L. Barbeito The molecular bases of Alzheimer's Disease and other neurodegenerative disorders Archives of Medicine Research 32 2001 367 381
20. G. Marsicano, S. Goodenough, K. Monory, H. Hermann, M. Eder, A. Cannich, S.C. Azad, M.G. Cascio, S.O. Gutierrez, M. van der Stelt, M.L. Lopez-Rodriguez, E. Casanova, G. Schutz, W. Zieglgansberger, V. Di Marzo, C. Behl, and B. Lutz CB1 cannabinoid receptors and on-demand defense against excitotoxicity Science 302 2003 84 88
21. 1 receptor blockade European Journal of Pharmacology 477 2003 219 225
22. R. Mechoulam, E. Fride, and V. Di Marzo Endocannabinoids European Journal of Pharmacology 359 1998 1 18
23. R. Mechoulam, D. Panikashvili, and E. Shohami Cannabinoids and brain injury: therapeutic implications Trends in Molecular Medicine 8 2002 58 61
24. N.G. Milton Anandamide and noladin ether prevent neurotoxicity of the human amyloid-β peptide Neuroscience Letters 332 2002 127 130
25. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65
26. D. Panikashvili, C. Simeonidou, S. Ben Shabat, L. Hanus, A. Breuer, R. Mechoulam, and E. Shohami An endogenous cannabinoid (2-AG) is neuroprotective after brain injury Nature 413 2001 527 531
27. A.C. Porter, and C.C. Felder The endocannabinoid nervous system:unique opportunities for therapeutic intervention Pharmacology and Therapeutics 90 2001 45 60
28. A.C. Porter, J.M. Sauer, M.D. Knierman, G.W. Becker, M.J. Berna, J. Bao, G.G. Nomikos, P. Carter, F.P. Bymaster, A.B. Leese, and C.C. Felder Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor Journal of Pharmacology and Experimental Therapeutics 301 2002 1020 1024
29. J.J. Rodrí-guez, K. Mackie, and V.M. Pickel Ultrastructural localization of the CB1 cannabinoid receptor in μ-opioid receptor patches of the rat caudate putamen nucleus Journal of Neuroscience 21 2001 823 833
30. 35S]guanylyl-5(O-(thio)- triphosphate binding in the basal ganglia of aged rats Neuroscience 84 1998 1075 1083
31. J. Romero, C.J. Hillard, M. Calero, and A. Rabano Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study Brain Research Molecular Brain Research 100 2002 85 93
32. T. Sugiura, S. Kondo, S. Kishimoto, T. Miyashita, S. Nakane, T. Kodaka, Y. Suhara, H. Takayama, and K. Waku Evidence that 2-arachidonylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells Journal of Biological Chemistry 275 2000 605 612
33. K. Tsou, S. Brown, M.C. Sanudo-Pena, K. Mackie, and J.M. Walker Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous sytem Neuroscience 83 1998 393 411
34. K. Tsou, M.I. Nogueron, S. Muthian, M.C. Sanudo-Pena, C.J. Hillard, D.G. Deutsch, and J.M. Walker Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry Neuroscience Letters 254 1998 137 140
35. L. Volicer, M. Stelly, J. Morris, J. McLaughlin, and B.J. Volicer Effects of Dronabinol on anorexia and disturbed behavior in patients with Alzheimer's Disease International Journal of Geriatry and Psychiatry 12 1997 913 919
36. 1) mediates inhibition of nitric oxide production by rat microglial cells Journal of Pharmacology and Experimental Therapeutics 288 1999 1357 1366
37. L. Walter, A. Franklin, A. Witting, C. Wade, Y. Xie, G. Kunos, K. Mackie, and N. Stella Nonpsychotropic cannabinoid receptors regulate microglial cell migration Journal of Neuroscience 23 2003 1398 1405
38. L. Walter, and N. Stella Cannabinoids and neuroinflammation British Journal of Pharmacology 141 2004 775 785
39. T.M. Westlake, A.C. Howlett, T.I. Bonner, L.A. Matsuda, and M. Herkenham Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains Neuroscience 63 1994 637 652
40. K. Williams, X. Alvarez, and A.A. Lackner Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system Glia 36 2001 156 164
41. T. Wyss-Coray, and L. Mucke Inflammation in neurodegenerative disease-A double-edged sword Neuron 35 2002 419 432